&Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $206M | Buy |
809,873
+49,143
| +6% | +$11.5M | 0.84% | 18 |
|
|
2026
Q1 | $186M | Sell |
760,730
-2,964
| -0.4% | -$690K | 0.92% | 15 |
|
|
2025
Q4 | $158M | Buy |
763,694
+100,418
| +15% | +$19.9M | 0.83% | 18 |
|
|
2025
Q3 | $123M | Buy |
663,276
+58,518
| +10% | +$10M | 0.79% | 16 |
|
|
2025
Q2 | $92.4M | Buy |
604,758
+135,433
| +29% | +$20.8M | 0.71% | 20 |
|
|
2025
Q1 | $76.9M | Buy |
469,325
+44,231
| +10% | +$6.92M | 0.82% | 14 |
|
|
2024
Q4 | $61.3M | Buy |
425,094
+172,710
| +68% | +$26.8M | 0.73% | 15 |
|
|
2024
Q3 | $40.8M | Buy |
252,384
+137,398
| +119% | +$21.9M | 0.79% | 12 |
|
|
2024
Q2 | $16.8M | Buy |
114,986
+83,044
| +260% | +$12.4M | 0.74% | 17 |
|
|
2024
Q1 | $5.05M | Buy |
31,942
+10,856
| +51% | +$1.73M | 0.7% | 24 |
|
|
2023
Q4 | $3.32M | Buy |
21,086
+7,000
| +50% | +$1.07M | 0.81% | 22 |
|
|
2023
Q3 | $2.19M | Buy |
14,086
+313
| +2% | +$51.6K | 1.02% | 20 |
|
|
2023
Q2 | $2.28M | Buy |
13,773
+224
| +2% | +$36.2K | 1.02% | 19 |
|
|
2023
Q1 | $2.1M | Buy |
13,549
+5
| +0% | +$807 | 1.01% | 19 |
|
|
2022
Q4 | $2.39M | Sell |
13,544
-131
| -1% | -$22.6K | 1.19% | 19 |
|
|
2022
Q3 | $2.23M | Buy |
13,675
+469
| +4% | +$79.4K | 1.29% | 14 |
|
|
2022
Q2 | $2.34M | Buy |
13,206
+739
| +6% | +$132K | 1.35% | 13 |
|
|
2022
Q1 | $2.21M | Buy |
12,467
+5,966
| +92% | +$1.02M | 1.24% | 12 |
|
|
2021
Q4 | $1.11M | Sell |
6,501
-65
| -1% | -$10.6K | 0.67% | 32 |
|
|
2021
Q3 | $1.06M | Buy |
6,566
+174
| +3% | +$29.7K | 0.67% | 36 |
|
|
2021
Q2 | $1.05M | Buy |
6,392
+107
| +2% | +$17.7K | 0.68% | 37 |
|
|
2021
Q1 | $1.03M | Buy |
6,285
+557
| +10% | +$90.1K | 0.75% | 35 |
|
|
2020
Q4 | $901K | Buy |
5,728
+218
| +4% | +$32.2K | 0.76% | 37 |
|
|
2020
Q3 | $820K | Buy |
5,510
+385
| +8% | +$57K | 0.83% | 37 |
|
|
2020
Q2 | $721K | Buy |
5,125
+67
| +1% | +$9.76K | 0.87% | 31 |
|
|
2020
Q1 | $663K | Buy |
5,058
+136
| +3% | +$19.3K | 1.03% | 23 |
|
|
2019
Q4 | $718K | Sell |
4,922
-218
| -4% | -$29.6K | 0.85% | 33 |
|
|
2019
Q3 | $665K | Buy |
5,140
+45
| +0.9% | +$5.93K | 0.86% | 34 |
|
|
2019
Q2 | $710K | Sell |
5,095
-473
| -8% | -$65.5K | 0.98% | 27 |
|
|
2019
Q1 | $778K | Buy |
5,568
+166
| +3% | +$22.2K | 1.11% | 22 |
|
|
2018
Q4 | $697K | Buy |
+5,402
| New | +$754K | 1.17% | 21 |
|
Other funds holding JNJ
&Partners's JNJ Position: Q2 2026 in Review
&Partners increased its Johnson & Johnson (JNJ) stake by 6.5% in Q2 2026, buying an estimated $11.5M and bringing the position to 809,873 shares worth $206M. The position accounts for 0.84% of the portfolio, ranked #18.
&Partners first reported a position in JNJ in Q4 2018 and has held it in 31 quarters since. 4,649 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- &Partners held 809,873 shares of Johnson & Johnson worth $206M as of Q2 2026.
- &Partners bought 49,143 Johnson & Johnson shares in Q2 2026, an estimated $11.5M.
- Johnson & Johnson made up 0.84% of &Partners's portfolio in Q2 2026, its #18 holding.
- &Partners first reported a position in Johnson & Johnson in Q4 2018 and has held it in 31 quarters since.
- 4,649 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.